Top Markets
Coin of the day
Hemostemix Inc. Hemostemix Inc.

Hemostemix Inc.

HEM
Rangering i aksjer #32158
Hemostemix Inc., a clinical stage biotechnology company, develops,... Hemostemix Inc., a clinical stage biotechnology company, develops, manufactures, and commercializes blood-derived stem cell therapies for medical conditions in Canada. Its lead product is ACP-01, which is in Phase II clinical trial for the treatment of vascular diseases, such as peripheral arterial disease, angina pectoris, and ischemia, as well as heart failure, ischemic and dilated cardiomyopathy, chronic limb threatening ischemia, vascular dementia, and brain function. The company also develops NCP-01, which is preclinical trial to evaluate effect on neuropathic pain and motor function recovery. Hemostemix Inc. is headquartered in Calgary, Canada.
Aksjekurs
$0.05504527
Sist synkronisert: 2026-08-17
Markedsverdi
$10.89M
Endring (1 dag)
15.38%
Endring (1 år)
-10.64%
Land
CA
Handel Hemostemix Inc. (HEM)

Kategori

Aksjeprishistorikk for Hemostemix Inc. (HEM)
Høyeste sluttskurs: $0.05 den 2026-08-01

Laveste sluttskurs: $13.17 den 2014-11-01
Aksjeprishistorikk for Hemostemix Inc. fra 2014 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -3.76%
2025 16.47%
2024 0.85%
2023 -52.75%
2022 -7.37%
2021 -60.16%
2020 105.00%
2019 -89.61%
2018 12.43%
2017 -27.92%
2016 -79.94%
2015 -39.73%
2014 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$515.58 32.24%
US
$992.01 50.00%
NL
$112.11 -36.37%
AU
$736.64 6.99%
CH
$1.06K -6.98%
KR